Ligand Pharmaceuticals Inc (LGND)
$322.75 +1.71% Close Oct 30, 2026 Live
Ligand Pharmaceuticals stock today
Ligand Pharmaceuticals closed at $322.75 on October 30, 2026, up 1.71% on the day. Over the past year it returned +72.5% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $6.47 billion.
$200.00$250.00$300.00
NovJan 2026MarMayJulSep
| Period | LGND | S&P 500 (SPY) |
|---|---|---|
| 1 month | +3.3% | -0.9% |
| 3 months | +8.9% | +2.1% |
| Year to date | +70.7% | +11.7% |
| 1 year | +72.5% | +12.4% |
| 3 years | +534.5% | +88.5% |
| 5 years | +121.2% | +76.0% |
Key statistics
- Market value
- $6.47B
- P/E (trailing)
- 127.1
- Forward P/E
- 28.5
- Price / sales
- 22.3
- 52-week range
- $181.65 to $322.75
About Ligand Pharmaceuticals
Ligand Pharmaceuticals acquires, develops, and commercializes pharmaceutical products.
Sector: Health Care
More on Ligand Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue +60% in the year to Dec 2025
- Valuation: P/E history and peersP/E 127.1, median 24.3 at its last 5 year ends
- Returns: what $1,000 became$1,000 ten years ago is $3,395 today
No forecast, no recommendation. This page describes Ligand Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.